Shinva Medical Instrument Co.,Ltd. (SHA:600587)
China · Delayed Price · Currency is CNY 13.60
+0.03 (0.22%)
May 15, 2026, 11:15 AM CST
Shinva Medical Instrument Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 491.74 | 528.13 | 691.61 | 654 | 500.07 | 556.49 |
Depreciation & Amortization | 233.46 | 233.46 | 203.17 | 213.16 | 197.34 | 200.91 |
Other Amortization | 41.49 | 41.49 | 49.62 | 45.12 | 43.78 | 52.84 |
Loss (Gain) From Sale of Assets | 0.99 | 0.99 | -0.6 | -3.75 | -2.51 | -3.53 |
Asset Writedown & Restructuring Costs | 80.26 | 80.26 | 17.33 | 12.87 | 2.03 | 4.51 |
Loss (Gain) From Sale of Investments | -39.1 | -39.1 | -70.82 | -93.65 | 7.48 | -172.94 |
Provision & Write-off of Bad Debts | - | - | 120.59 | 116.98 | 64.33 | 35.09 |
Other Operating Activities | 354.55 | 86.86 | 59.78 | 67.35 | 84.52 | 103.56 |
Change in Accounts Receivable | 16.37 | 16.37 | -615.58 | 6.82 | -329.1 | -145.01 |
Change in Inventory | 398.24 | 398.24 | 190.85 | -540.03 | -726.54 | 18.01 |
Change in Accounts Payable | -639.18 | -639.18 | -187.55 | 563.58 | 600.94 | 703.35 |
Operating Cash Flow | 931.92 | 700.64 | 450.73 | 1,030 | 388.05 | 1,403 |
Operating Cash Flow Growth | 86.01% | 55.44% | -56.24% | 165.46% | -72.33% | 27.72% |
Capital Expenditures | -229.06 | -381.55 | -420.88 | -535.77 | -247.58 | -274.36 |
Sale of Property, Plant & Equipment | 0.68 | 1.04 | 0.24 | 2.59 | 0.82 | 18.69 |
Cash Acquisitions | - | - | - | - | 0.67 | - |
Divestitures | 103.56 | 103.56 | - | 1.24 | - | 162.48 |
Investment in Securities | 22.43 | 4.76 | 43.31 | -4.67 | -40.5 | 205.09 |
Other Investing Activities | -618.75 | 89.34 | 58.64 | 16.71 | 5.36 | 10.31 |
Investing Cash Flow | -721.14 | -182.85 | -318.71 | -519.9 | -281.22 | 163.89 |
Long-Term Debt Issued | - | 1,195 | 1,024 | 1,153 | 1,321 | 1,071 |
Long-Term Debt Repaid | - | -1,150 | -1,081 | -1,232 | -1,214 | -2,346 |
Net Debt Issued (Repaid) | -17.07 | 44.9 | -56.14 | -78.69 | 106.99 | -1,275 |
Issuance of Common Stock | - | - | - | 1,276 | 62.46 | - |
Common Dividends Paid | -341.1 | -342.62 | -329.03 | -103.8 | -96.95 | -128.68 |
Other Financing Activities | -25.7 | -22.6 | -21.96 | -27.95 | -44.68 | -4.12 |
Financing Cash Flow | -383.88 | -320.32 | -407.13 | 1,066 | 27.81 | -1,407 |
Foreign Exchange Rate Adjustments | -3.55 | -0.37 | 4.03 | 6.95 | 1.4 | 0.24 |
Net Cash Flow | -176.64 | 197.09 | -271.07 | 1,583 | 136.04 | 159.31 |
Free Cash Flow | 702.87 | 319.09 | 29.85 | 494.34 | 140.47 | 1,128 |
Free Cash Flow Growth | - | 969.00% | -93.96% | 251.91% | -87.55% | 24.42% |
Free Cash Flow Margin | 7.26% | 3.28% | 0.30% | 4.94% | 1.51% | 11.90% |
Free Cash Flow Per Share | 1.15 | 0.53 | 0.05 | 0.82 | 0.27 | 2.14 |
Cash Income Tax Paid | 405.83 | 405.83 | 434.79 | 419.57 | 486.1 | 546.32 |
Levered Free Cash Flow | 740.99 | 245.47 | -359.7 | 311.47 | 115.25 | 948.4 |
Unlevered Free Cash Flow | 740.99 | 245.47 | -331.71 | 340.89 | 150.83 | 996.06 |
Change in Working Capital | -231.46 | -231.46 | -619.94 | 18.05 | -508.67 | 625.29 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.